SO-25 A multicenter phase II study of eribulin in patients with BRAF V600E mutant metastatic colorectal cancer: BRAVERY study (EPOC1701)

Autor:	T. Satoh, Eiji Shinozaki, Takayuki Yoshino, A. Ohtsu, Tomohiro Nishina, Masashi Wakabayashi, Hiroko Bando, N. Hirano, Hiroya Taniguchi, Taito Esaki, Nozomu Fuse, N. Fujishiro, A. Sato, Daisuke Kotani, Yasuo Komatsu, Keiichi Takahashi, H. Ono, Toshiki Masuishi, Sachiyo Nomura, Takako Eguchi Nakajima
Rok vydání:	2020
Předmět:	Oncology medicine.medical_specialty business.industry Colorectal cancer Mutant Phases of clinical research Hematology medicine.disease BRAF V600E chemistry.chemical_compound chemistry Internal medicine Medicine In patient business Eribulin
Zdroj:	Annals of Oncology. 31:S226
ISSN:	0923-7534
DOI:	10.1016/j.annonc.2020.04.040
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::772e260228e425c8b7e34a737e804b67 https://doi.org/10.1016/j.annonc.2020.04.040 Zobrazit plný text záznamu